icgc (international cancer genome consortium)

What is the International Cancer Genome Consortium (ICGC)?

The International Cancer Genome Consortium (ICGC) is a collaborative global initiative aimed at comprehensively mapping the genomic changes in various types of cancer. Launched in 2008, the ICGC's primary goal is to generate a comprehensive catalog of genomic abnormalities associated with cancer to improve the diagnosis, treatment, and prevention of the disease.

Frequently asked queries:

What is the International Cancer Genome Consortium (ICGC)?
Why was the ICGC established?
What are the main objectives of the ICGC?
How does the ICGC operate?
What types of data does the ICGC collect?
What are some significant achievements of the ICGC?
How can researchers access ICGC data?
What is the future of the ICGC?
How can the public and policymakers support the ICGC?
What Role Do Healthcare Providers Play in Ensuring Quality Cancer Care?
Where Can Patients Receive Strontium 89?
What is Graduate and Postdoctoral Training in Cancer?
Are There Any Approved Adenovirus-Based Cancer Therapies?
How Effective Are Checkpoint Inhibitors?
What is IBM Watson API?
What are the Consequences of Not Obtaining Ethics Approval?
What Are the Applications of ATP Assays in Cancer?
What Types of Donations are Needed?
What is Limited Generalizability?
What is Atlas-Based Segmentation?
Top Searches
Brain Tumor Breast cancer cancer Cancer Diagnostics Cancer Genomics Chemotherapy Essential Thrombocythemia hepatocellular carcinoma Lung Cancer Molecular Biomarkers Nanotechnology Non-Hodgkin’s Lymphoma Radiation-Induced Malignancies
Follow Us

Partnered Content Networks

Relevant Topics